These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25937612)

  • 1. Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan.
    Khan MI; Pach A; Khan GM; Bajracharya D; Sahastrabuddhe S; Bhutta W; Tahir R; Soofi S; Thapa CB; Joshi N; Puri MK; Shrestha P; Upreti SR; Clemens JD; Bhutta Z; Ochiai RL
    Vaccine; 2015 Jun; 33 Suppl 3():C62-7. PubMed ID: 25937612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform.
    Agtini MD; Ochiai RL; Soeharno R; Lee HJ; Sundoro J; Hadinegoro SR; Han OP; Tana L; Halim FX; Ghani L; Delima ; Lestari W; Sintawati FX; Kusumawardani N; Malik R; Santoso TS; Nadjib M; Soeroso S; Wangsasaputra F; Ali M; Ivanoff B; Galindo CM; Pang T; Clemens JD; Suwandono A; Acosta CJ
    Public Health; 2006 Nov; 120(11):1081-7. PubMed ID: 17005220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan.
    Pach A; Tabbusam G; Khan MI; Suhag Z; Hussain I; Hussain E; Mumtaz U; Haq IU; Tahir R; Mirani A; Yousafzai A; Sahastrabuddhe S; Ochiai RL; Soofi S; Clemens JD; Favorov MO; Bhutta ZA
    J Health Commun; 2013; 18(3):306-24. PubMed ID: 23330632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project.
    Garrett DO; Longley AT; Aiemjoy K; Yousafzai MT; Hemlock C; Yu AT; Vaidya K; Tamrakar D; Saha S; Bogoch II; Date K; Saha S; Islam MS; Sayeed KMI; Bern C; Shakoor S; Dehraj IF; Mehmood J; Sajib MSI; Islam M; Thobani RS; Hotwani A; Rahman N; Irfan S; Naga SR; Memon AM; Pradhan S; Iqbal K; Shrestha R; Rahman H; Hasan MM; Qazi SH; Kazi AM; Saddal NS; Jamal R; Hunzai MJ; Hossain T; Marks F; Carter AS; Seidman JC; Qamar FN; Saha SK; Andrews JR; Luby SP
    Lancet Glob Health; 2022 Jul; 10(7):e978-e988. PubMed ID: 35714648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.
    Bajracharya D; Khan MI; Pach A; Shrestha P; Joshi N; Upreti SR; Wierzba T; Puri M; Sahastrabuddhe S; Ochiai RL
    PLoS One; 2014; 9(1):e77974. PubMed ID: 24400067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Theiss-Nyland K; Shakya M; Colin-Jones R; Voysey M; Smith N; Karkey A; Dongol S; Pant D; Farooq YG; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S67-S73. PubMed ID: 30845329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI; Ochiai RL; Clemens JD
    Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.
    Colin-Jones R; Shakya M; Voysey M; Theiss-Nyland K; Smith N; Pant D; Liu X; Tonks S; Mazur O; Farooq YG; Kelly S; Adhikari A; Dongol S; Karkey A; Shrestha S; Basnyat B; Pollard AJ
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S138-S145. PubMed ID: 30845335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan.
    Batool R; Yousafzai MT; Qureshi S; Muhammad S; Qazi I; Sadaf T; Ashorn P; Qamar FN
    Vaccine; 2023 Aug; 41(37):5376-5382. PubMed ID: 37463829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial.
    Yang J; Acosta CJ; Si GA; Zeng J; Li CY; Liang DB; Ochiai RL; Page AL; Danovaro-Holliday MC; Zhang J; Zhou BD; Liao HZ; Wang ML; Tan DM; Tang ZZ; Gong J; Park JK; Ali M; Ivanoff B; Liang GC; Yang HH; Pang T; Xu ZY; Donner A; Galindo CM; Dong BQ; Clemens JD
    BMC Public Health; 2005 May; 5():49. PubMed ID: 15904514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy.
    Thiem VD; Danovaro-Holliday MC; Canh DG; Son ND; Hoa NT; Thuy DT; Ochiai RL; Lan NT; Hop TQ; Ali M; Park JK; Abu-Elyazeed R; Holliday K; Ivanoff B; Anh DD; Pang T; Donner A; Galindo CM; Trach DD; Clemens JD; Acosta CJ
    Southeast Asian J Trop Med Public Health; 2006 May; 37(3):515-22. PubMed ID: 17120972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam.
    Kaljee LM; Pham V; Son ND; Hoa NT; Thiem VD; Canh DG; Thoa le TK; Ali M; Ochiai RL; Danovaro-Holliday MC; Acosta CJ; Stanton B; Clemens J
    Trop Med Int Health; 2007 Jan; 12(1):25-36. PubMed ID: 17207145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project.
    Carter AS; Luby SP; Garrett DO
    Clin Infect Dis; 2020 Dec; 71(Suppl 3):S191-S195. PubMed ID: 33258930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typhoid fever vaccination strategies.
    Date KA; Bentsi-Enchill A; Marks F; Fox K
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C55-61. PubMed ID: 25902360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of typhoid vaccines in Asia: the DOMI experience.
    Ochiai RL; Acosta CJ; Agtini M; Bhattacharya SK; Bhutta ZA; Do CG; Dong B; Chen X; Stanton B; Kaljee L; Nyamete A; Galindo CM; von Seidlein L; DeRoeck D; Jodar L; Clemens JD
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S34-8. PubMed ID: 17582567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
    Miyazu M; Kikuchi H; Hamada A; Fukushima S; Ouchi K; Bosch Castells V; Mihara H; Bonnet MC
    Vaccine; 2015 Nov; 33(48):6697-702. PubMed ID: 26518404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.